Legend:
CC = Baltimore Convention Center, H = Hilton Baltimore
* = applied session ! = JSM meeting theme
Activity Details
|
|
|
|
216 *
|
Mon, 7/31/2017,
2:00 PM -
3:50 PM
|
CC-328
|
|
Statistical Opportunities in Disease Interception: Screening, Intervening, and Evaluating Benefit-Risk Trade-Offs — Topic Contributed Papers
|
|
Section on Medical Devices and Diagnostics , Section on Statistics in Epidemiology , Section on Risk Analysis
|
|
Organizer(s): Rachael L. DiSantostefano, Janssen R&D
|
|
Chair(s): Bennett Levitan, Janssen R&D
|
|
2:05 PM
|
A Risk Stratification Approach for Improved Interpretation of Diagnostic Accuracy Statistics
—
Hormuzd Katki, National Cancer Institute ; Mark Schiffman, National Cancer Institute
|
|
2:25 PM
|
Personalizing Early Detection for Ovarian Cancer with Hierarchical Longitudinal Models of a Blood Biomarker: Experience in Multiple Prospective Screening Trials
—
Steven Skates, MGH/Biostatistics Center
|
|
2:45 PM
|
Personalizing Early Detection for Alzheimer's Disease: Biomarker Assessment in the Absence of a Gold Standard
—
Zheyu Wang, Johns Hopkins University ; Yanxun Xu, Johns Hopkins University ; Marilyn Albert, Johns Hopkins University
|
|
3:05 PM
|
Alzheimer's Intervention Case Study: Patient Preferences and Benefit-Risk Tradeoffs in Interception of Alzheimer's Disease
—
Rachael L. DiSantostefano, Janssen R&D ; Shelby Reed, Duke University ; Reed Johnson, Duke University ; Jui-Chen Yang, Duke University ; Johannes Streffer, Janssen R&D ; Bennett Levitan, Janssen R&D
|
|
3:25 PM
|
Evaluating Risk Prediction Tests to Guide Decisions on Prophylactic Treatment
—
Gene Pennello, Food and Drug Administration ; Robert L Becker, Food and Drug Administration
|
|
3:45 PM
|
Floor Discussion
|
|
